Eli Lilly and Company[Grants and Funding] - Search Results

Year	Number of Results
2017	3
2018	35
2019	74
2020	107
2021	76
2022	50
2023	66
2024	49

1

Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme.

Bergenstal RM, Philis-Tsimikas A, Wysham C, Carr MC, Bue-Valleskey JM, Botros FT, Blevins T, Rosenstock J. Bergenstal RM, et al. Diabetes Obes Metab. 2024 Apr 28. doi: 10.1111/dom.15604. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38679838 Review.

2

Correction to: Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.

[No authors listed] [No authors listed] Inflamm Bowel Dis. 2024 Apr 27:izae096. doi: 10.1093/ibd/izae096. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38676912 No abstract available.

3

Effect size varies based on calculation method and may affect interpretation of treatment effect: an illustration using randomised clinical trials in osteoarthritis.

Schnitzer TJ, Conaghan PG, Berenbaum F, Abraham L, Cappelleri JC, Bushmakin AG, Viktrup L, Yang R, Brown MT. Schnitzer TJ, et al. Adv Rheumatol. 2024 Apr 22;64(1):31. doi: 10.1186/s42358-024-00358-y. Adv Rheumatol. 2024. PMID: 38650049

4

Early-Onset Type 2 Diabetes and Tirzepatide Treatment: A Post Hoc Analysis From the SURPASS Clinical Trial Program.

Zeitler P, Galindo RJ, Davies MJ, Bergman BK, Thieu VT, Nicolay C, Allen S, Heine RJ, Lee CJ. Zeitler P, et al. Diabetes Care. 2024 Apr 19:dc232356. doi: 10.2337/dc23-2356. Online ahead of print. Diabetes Care. 2024. PMID: 38639997

5

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer.

Gardner FP, Wainberg ZA, Fountzilas C, Bahary N, Womack MS, Macarulla T, Garrido-Laguna I, Peterson PM, Borazanci E, Johnson M, Ceccarelli M, Pelzer U. Gardner FP, et al. Cancers (Basel). 2024 Mar 28;16(7):1323. doi: 10.3390/cancers16071323. Cancers (Basel). 2024. PMID: 38611000 Free PMC article.

6

Real-world treatment satisfaction with dulaglutide, and its influencing factors, in a Chinese population with type 2 diabetes mellitus.

Guo L, Xi Y, Li L, Guo K, Wu J, Xu J, Wang Y, Wu G, Si S. Guo L, et al. Diabetes Obes Metab. 2024 Apr 10. doi: 10.1111/dom.15590. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38600796 No abstract available.

7

Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry.

Caforio ALP, Kaski JP, Gimeno JR, Elliott PM, Laroche C, Tavazzi L, Tendera M, Fu M, Sala S, Seferovic PM, Heliö T, Calò L, Blagova O, Amin A, Kindermann I, Sinagra G, Frustaci A, Bonnet D, Charron P, Maggioni AP; CMY Registry Investigators. Caforio ALP, et al. Eur Heart J. 2024 Apr 10:ehae169. doi: 10.1093/eurheartj/ehae169. Online ahead of print. Eur Heart J. 2024. PMID: 38594778

8

Infective Endocarditis in Belgium: Prospective Data in Adults from the ESC EORP European Endocarditis Registry.

Roosens B, Cosyns B, Lancellotti P, Laroche C, Selton-Suty C, Pasquet A, De Sutter J, Unger P, Paelinck B, Vermeersch P, Motoc A, Galloo X, Iung B, Habib G, On Behalf Of The Euro-Endo Investigators Group. Roosens B, et al. J Clin Med. 2024 Feb 28;13(5):1371. doi: 10.3390/jcm13051371. J Clin Med. 2024. PMID: 38592201 Free PMC article.

9

Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials.

Giorgino F, Franco DR, Nicolay C, Hemmingway A, Rodríguez Á, Wiese RJ. Giorgino F, et al. Diabetes Care. 2024 Mar 26:dc232366. doi: 10.2337/dc23-2366. Online ahead of print. Diabetes Care. 2024. PMID: 38530948

10

Effect of tirzepatide on body fat distribution pattern in people with type 2 diabetes.

Cariou B, Linge J, Neeland IJ, Dahlqvist Leinhard O, Petersson M, Fernández Landó L, Bray R, Rodríguez Á. Cariou B, et al. Diabetes Obes Metab. 2024 Mar 26. doi: 10.1111/dom.15566. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38528819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

387 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Results by year